Loading company…
ImmunoTarget Therapeutics, Inc.
PrivateWon a federal SBIR/STTR research award from HHS and other federal agencies.
Department of Health and Human ServicesNational Institutes of Health
- SAM UEI
- RKHMXCMM1SA3
- Founded
- —Source: [GOV]
- Headquarters
- Irvine, CaliforniaSource: [GOV]
- Headcount
- 2Source: [GOV]
- Stage
- Seed
- Sector
- Healthcare
$0Source: [GOV]Total raised
UndisclosedSource: [GOV]Last valuation
Overview
ImmunoTarget Therapeutics, Inc. has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $355,000 in 2022. These are non-dilutive federal research grants, not equity financing. The company is based in Irvine, California.
Funding rounds
1 rounds- SBIR Phase I award (HHS)GrantJan 2022Source: [GOV]$355K—post-money
Investors
No investors recorded yet for ImmunoTarget Therapeutics, Inc..
Add an investorPeople
LeadershipAcquisitions
ImmunoTarget Therapeutics, Inc. has no recorded acquisitions.
Add an acquisitionExits
Still private — no exit on record.
Record an exitDiversity investments
No diversity signals recorded yet for ImmunoTarget Therapeutics, Inc..
Add diversity data